NEW YORK, March 14, 2014 /PRNewswire/ --
Today, Analysts Review released its analysts' notes regarding Air Products & Chemicals Inc. (NYSE:APD), Praxair Inc. (NYSE: PX), Minerals Technologies Inc. (NYSE: MTX), Sociedad Quimica y Minera de Chile S.A. (NYSE: SQM), and Syngenta AG (NYSE: SYT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Air Products & Chemicals Inc. Analyst Notes
On March 11, 2014, Air Products & Chemicals Inc. (Air Products) reported that the Company will be showcasing its range of industrial gases and advanced technologies for a variety of biopharmaceutical and pharmaceutical applications at INTERPHEX in New York City from March 18, 2014 to March 20, 2014 at booth #2675. The Company stated that Candice Palmer, Ph.D. at Air Products, will discuss the Company's proprietary cryogenic spray crystallization technology during a technical session scheduled on March 18, 2014 at 2:45 p.m. in Room 1E12.Air Productsadded that it will also feature a full range of industrial gases, along with NF/USP medical gases - available in a variety of delivery options to match each customer's requirements. The full analyst notes on Air Products & Chemicals Inc. are available to download free of charge at:
http://www.AnalystsReview.com/03142014/APD/report.pdf
Praxair Inc. Analyst Notes
On March 11, 2014, Praxair Inc. (Praxair) announced that it successfully acquired two independent distributors of packaged gas and welding supplies, United Welding Supplies, LLC (United) in Texas and Best Welders Supply, Inc. (Best) in Oklahoma, with combined annual sales of c.$30 million in 2013. The Company stated that financial terms of the transactions were not disclosed. Scott Kaltrider, President, Praxair Distribution, Inc. (a subsidiary of the Company) commented, "We have been steadily growing our packaged and small bulk business in Houston and the Gulf Coast region. In addition, the growing Tulsa region has a strong economy supported by a healthy oil and gas industry and aerospace equipment manufacturing. The acquisition of these well-established distributors enables Praxair to further strengthen its presence in these important geographies. We are excited to have them join the Praxair team and look forward to serving our new customers." The full analyst notes on Praxair Inc. are available to download free of charge at:
http://www.AnalystsReview.com/03142014/PX/report.pdf
Minerals Technologies Inc. Analyst Notes
On March 10, 2014, Minerals Technologies Inc. (Minerals Technologies) together with AMCOL International Corporation (AMCOL) announced that they have signed a definitive merger agreement wherein Minerals Technologies will acquire AMCOL for $45.75 per share in cash, or a total value of c.$1.7 billion. According to the Company, the transaction has been unanimously approved by the Boards of Directors for both Minerals Technologies and AMCOL, with closingexpected in H1 FY 2014, subject to customary closing conditions. Joseph C. Muscari, Chairman and CEO of Minerals Technologies commented, "The combination of MTI and AMCOL will create a minerals platform that is well-positioned for growth through geographic expansion and new product innovation. We look forward to welcoming AMCOL employees to MTI. Together, we will be better positioned to take advantage of even more opportunities for innovation and growth in the global minerals industry." The full analyst notes on Minerals Technologies Inc. are available to download free of charge at:
http://www.AnalystsReview.com/03142014/MTX/report.pdf
Sociedad Quimica y Minera de ChileS.A.Analyst Notes
On March 5, 2014, Sociedad Quimica y Minera de Chile S.A.(SQM) announced that its Board of Directors, at the Ordinary Meeting on March 4, 2014, unanimously decided to recommend at the next Annual General Shareholders' Meeting of SQM to distribute and pay, by way of final dividend, 50% of the distributable net income acquired by SQM during the exercise of FY 2013. The Company stated that subject to the approval of SQM's shareholder at the next Annual Meeting on April 25, 2014, SQM will pay a final dividend of c.$0.89 per share as a consequence of the distributable net income obtained during FY2013. The full analyst notes on Sociedad Quimica y Minera de Chile S.A. are available to download free of charge at:
http://www.AnalystsReview.com/03142014/SQM/report.pdf
Syngenta AG Analyst Notes
On March 3, 2014, Syngenta AG (Syngenta) announced that ELATUS™, a breakthrough foliar fungicide, was approved by the Brazilian authorities. The Company informed that ELATUS, a combination of Syngenta's new SDHI chemistry SOLATENOL™ and AMISTAR®, offers protection against soybean rust- devastating disease that greatly affects impact yields. Syngenta stated that ELATUS will be available in Brazil for the next season starting in September 2014. Syngenta Chief Operating Officer, John Atkin, commented, "ELATUS is a powerful addition to our leading soybean portfolio and will be an important part of our integrated offers.Latin American soybean growers now have a new tool to control rust and manage resistance. This will enable them to increase production in response to growing global demand while optimizing their use of natural resources." The full analyst notes on Syngenta AG are available to download free of charge at:
http://www.AnalystsReview.com/03142014/SYT/report.pdf
About Analysts Review
We provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.
=============
EDITOR NOTES:
- This is not company news. We are an independent source and our views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
- This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
- If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] AnalystsReview.com.
- For any urgent concerns or inquiries, please contact us at compliance [at] AnalystsReview.com.
- Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] AnalystsReview.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Analysts Review in this article or report according to the Procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts Review
